TOLREMO therapeutics AG
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.tolremo.com
A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid TumorAdult Solid TumorAdult DiseaseCancerNSCLC
- Interventions
- First Posted Date
- 2024-05-07
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- TOLREMO therapeutics AG
- Target Recruit Count
- 50
- Registration Number
- NCT06403436
- Locations
- 🇪🇸
NEXT Oncology Barcelona, Barcelona, Spain
🇪🇸Vall d'Hebron Institute of Oncology, Barcelona, Spain
🇪🇸NEXT Oncology Madrid, Madrid, Spain
© Copyright 2025. All Rights Reserved by MedPath